Terminal Sterilization of Prefilled Containers

• US 20090012466A1
• Filed: 09/15/2008
• Published: 01/08/2009
• Est. Priority Date: 12/15/2003
• Status: Abandoned Application

• Current Assignee: Becton, Dickinson & Co
• Original Assignee: Becton, Dickinson & Co
• Inventors: Ren, Jane, Paterson, Patti, Zhao, Xia, Odell, Robert
• Application Number:
  US12/210,377
• Publication Number:
  US 20090012466A1
• Time in Patent Office: Days
• US Class Current: 604/93.10
• CPC Class Codes: A61L 2/081 Gamma radiation

Abstract

A method for inhibiting adverse reaction of the contents of a prefilled container during a radiation sterilization procedure is disclosed. In the method, a container which is made of a material including a radiation stable polyolefin is prefilled with a medium prior to being subjected to a gamma irradiation sterilization treatment. By using a radiation stable polyolefin material as the container, such as a polyolefin with a radiation stabilizer additive, and by prefilling the container prior to the gamma irradiation treatment, the container can be effectively sterilized without adversely affecting its contents.

Claims

1-45. -45. (canceled)

46. A method of reducing the amount of oxidizable material in a fluid medium contained within a container subjected to gamma irradiation, comprising:

providing a fluid medium;

placing the fluid medium in a container comprising a radiation stable polyolefin material; and

exposing the container containing the fluid medium therein to gamma radiation at a predetermined intensity and for a predetermined time period resulting in an amount of oxidizable material in the fluid medium contained within the container that is less than the amount of oxidizable material present in the fluid medium if the container had been exposed to gamma radiation at the same intensity and for the same time period prior to placing the fluid medium within the container.

47. A method as in claim 46, wherein the medium is selected from the group consisting of a therapeutic fluid and a non-therapeutic fluid.

48. A method as in claim 47, wherein the medium comprises a drug for parenteral administration to the body.

49. A method as in claim 47, wherein the medium comprises saline water.

50. A method as in claim 46, wherein the medium has a pH between about 4.5 and about 7.0 after radiation sterilization.

51. A method as in claim 46, wherein the medium exhibits ultraviolet absorbance of less than about 0.2 at a wavelength between 220 and 340 nm.

52. A method as in claim 46, wherein the medium includes less than about 3.4 ppm of hydrogen peroxide.

53. A method as in claim 46, wherein the container is manufactured from a composition comprising a polyolefin, a mobilizing amount of a liquid mobilizer compatible with said polyolefin, and a radiation stabilizing amount of a hindered piperidine stabilizer.

54. A method as in claim 53, wherein the composition of the container further comprises a clarifying amount of a dibenzylidene sorbitol alkyl thioether clarifier.

55. A method as in claim 53, wherein the composition of the container further comprises a nucleating agent comprising a 2,2′

-methylene-bis(4,6-di-t-butylphenol)phosphate salt.

56. A method as in claim 55, wherein the 2,2′

-methylene-bis(4,6-di-t-butylphenol)phosphate salt is selected from the group consisting of sodium 2,2′

-methylene-bis(4,6-di-t-butylphenol)phosphate and aluminum 2,2′

-methylene-bis(4,6-di-t-butylphenol) phosphate.

57. A method as in claim 53, wherein the composition of the container further comprises about 0.1 to 10% of an additional polymer.

58. A method as in claim 53, wherein the polyolefin is selected from the group consisting of polyethylene, polypropylene, polymethylpentene, polytetrafluoroethylene and copolymers thereof.

59. A method as in claim 53, wherein the mobilizing additive is selected from the group consisting of a hydrocarbon oil, phthalic ester oil, polymer grease, vegetable oil, mineral oil and silicone oil.

60. A method as in claim 53, wherein the stabilizer is a bis(4-piperidinyl) diester of a dicarboxylic acid.

61. A method as in claim 46, where the gamma irradiation ranges from about 10 kGy to about 60 kGy.

62. A method as in claim 46, wherein the container comprises a bag for intravenous fluid delivery.

63. A method as in claim 46, wherein the container comprises a syringe.

64. A sterile syringe containing a fluid medium having less than about 3.4 ppm of oxidizable substances prepared by the method of claim 46.